{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T01:38:10Z","timestamp":1793151490259,"version":"4.5.0"},"reference-count":38,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,9]]},"abstract":"<jats:sec>\n            <jats:title>Purpose to review<\/jats:title>\n            <jats:p>Juvenile idiopathic arthritis (JIA) is the most common chronic rheumatic disease in children, characterized by persistent joint inflammation with heterogeneous clinical subtypes. Early diagnosis and targeted treatment remain critical to improving long-term outcomes. In recent years, research has increasingly focused on the identification and validation of biomarkers to enhance diagnostic precision, predict disease course, and guide therapeutic decisions.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent findings<\/jats:title>\n            <jats:p>Calprotectin (S100A8\/A9) is a pro-inflammatory protein complex released by activated neutrophils and monocytes. In JIA, serum and synovial fluid calprotectin levels correlate with disease activity and may outperform traditional markers like C-reactive protein and erythrocyte sedimentation rate. Evidence suggests that elevated calprotectin levels can predict flares and subclinical inflammation, making it a promising biomarker for monitoring and prognosis in JIA. Novel biomarkers including microRNAs show potential for differentiating disease subtypes and monitoring treatment response. Proteomic and metabolomic profiling are also uncovering candidates that may improve early diagnosis and personalized management.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>Biomarkers have emerged as pivotal tools in the management of JIA, offering significant advantages in both therapeutic decision-making and long-term monitoring. In the future, a robust biomarker framework holds the potential to improve early diagnosis, guide personalized treatment strategies, and enhance outcome prediction\u2014ultimately contributing to more effective and individualized care for patients with JIA.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/bor.0000000000001109","type":"journal-article","created":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T08:01:31Z","timestamp":1750406491000},"page":"308-315","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":6,"title":["Biomarkers in juvenile idiopathic arthritis: towards precision diagnosis and personalized therapy?"],"prefix":"10.1097","volume":"37","author":[{"given":"Luciana","family":"Breda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saverio","family":"La Bella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armando","family":"Di Ludovico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,6,20]]},"reference":[{"key":"R1-20250728","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1016\/S0140-6736(11)60244-4","article-title":"Juvenile idiopathic arthritis","volume":"377","author":"Prakken","year":"2011","journal-title":"Lancet"},{"key":"R2-20250728","first-page":"390","article-title":"International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001","volume":"31","author":"Petty","year":"2004","journal-title":"J Rheumatol"},{"key":"R3-20250728","doi-asserted-by":"crossref","first-page":"e70007","DOI":"10.1111\/1756-185X.70007","article-title":"Serum biomarkers and musculoskeletal ultrasound for assessment of disease activity in patients with juvenile idiopathic arthritis during tocilizumab therapy","volume":"27","author":"Elsayed","year":"2024","journal-title":"Int J Rheum Dis"},{"key":"R4-20250728","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1186\/s13075-018-1764-z","article-title":"Calprotectin strongly and independently predicts relapse in rheumatoid arthritis and polyarticular psoriatic arthritis patients treated with tumor necrosis factor inhibitors: a 1-year prospective cohort study","volume":"20","author":"Inciarte-Mundo","year":"2018","journal-title":"Arthritis Res Ther"},{"key":"R5-20250728","doi-asserted-by":"crossref","first-page":"202","DOI":"10.5114\/reum.2020.98431","article-title":"Blood calprotectin in children with juvenile idiopathic arthritis: relationship to flare development after discontinuation of treatment","volume":"58","author":"Boyko","year":"2020","journal-title":"Reumatologia"},{"key":"R6-20250728","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s12969-022-00701-x","article-title":"Myeloid-related protein 8\/14 in plasma and serum in patients with new-onset juvenile idiopathic arthritis in real-world setting in a single center","volume":"20","author":"Keskitalo","year":"2022","journal-title":"Pediatr Rheumatol Online J"},{"key":"R7-20250728","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1093\/cei\/uxae071","article-title":"The immune landscape of the inflamed joint defined by spectral flow cytometry","volume":"218","author":"Attrill","year":"2024","journal-title":"Clin Exp Immunol"},{"key":"R8-20250728","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s13075-024-03347-0","article-title":"S100 proteins as potential predictive biomarkers of abatacept response in polyarticular juvenile idiopathic arthritis","volume":"26","author":"Brunner","year":"2024","journal-title":"Arthritis Res Ther"},{"key":"R9-20250728","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.3390\/ijms24021671","article-title":"The role of serum calprotectin in defining disease outcomes in non-systemic juvenile idiopathic arthritis: a pilot study","volume":"24","author":"d\u2019Angelo","year":"2023","journal-title":"Int J Mol Sci"},{"key":"R10-20250728","doi-asserted-by":"crossref","first-page":"e004317","DOI":"10.1136\/rmdopen-2024-004317","article-title":"Inflammatory biomarkers predicting long-term remission and active disease in juvenile idiopathic arthritis: a population-based study of the Nordic JIA cohort","volume":"10","author":"Glerup","year":"2024","journal-title":"RMD Open"},{"key":"R11-20250728","doi-asserted-by":"crossref","first-page":"1422916","DOI":"10.3389\/fped.2024.1422916","article-title":"Diagnostic accuracy of serum calprotectin measured by CLIA and EIA in juvenile idiopathic arthritis: a proof-of-concept study","volume":"12","author":"Codes-M\u00e9ndez","year":"2024","journal-title":"Front Pediatr"},{"key":"R12-20250728","doi-asserted-by":"crossref","article-title":"A novel serum calprotectin (MRP8\/14) particle-enhanced immuno-turbidimetric assay (sCAL turbo) helps to differentiate systemic juvenile idiopathic arthritis from other diseases in routine clinical laboratory settings","author":"Foell","DOI":"10.1186\/s40348-023-00168-0"},{"key":"R13-20250728","doi-asserted-by":"crossref","first-page":"4861","DOI":"10.3390\/jcm10214861","article-title":"Serum calprotectin a potential biomarker in juvenile idiopathic arthritis: a meta-analysis","volume":"10","author":"Altobelli","year":"2021","journal-title":"J Clin Med"},{"key":"R14-20250728","first-page":"185","article-title":"Serum calprotectin and joint ultrasound in the definition of disease relapse in nonsystemic juvenile idiopathic arthritis: a prospective longitudinal study","volume":"42","author":"d\u2019Angelo","year":"2024","journal-title":"Clin Exp Rheumatol"},{"key":"R15-20250728","doi-asserted-by":"crossref","first-page":"499","DOI":"10.3390\/metabo14090499","article-title":"Identification of plasma metabolomic biomarkers of juvenile idiopathic arthritis","volume":"14","author":"Kumar","year":"2024","journal-title":"Metabolites"},{"key":"R16-20250728","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s12969-024-01041-8","article-title":"The plasma metabolome of juvenile idiopathic arthritis varies according to subtype and underlying inflammatory status","volume":"22","author":"Kwon","year":"2024","journal-title":"Pediatr Rheumatol"},{"key":"R17-20250728","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s12969-024-00986-0","article-title":"Causal relationship between serum metabolites and juvenile idiopathic arthritis: a mendelian randomization study","volume":"22","author":"Zhang","year":"2024","journal-title":"Pediatr Rheumatol"},{"key":"R18-20250728","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/BOR.0000000000000948","article-title":"When to stop medication in juvenile idiopathic arthritis","volume":"35","author":"Abel","year":"2023","journal-title":"Curr Opin Rheumatol"},{"key":"R19-20250728","doi-asserted-by":"crossref","first-page":"991","DOI":"10.3390\/biology12070991","article-title":"MicroRNAs in juvenile idiopathic arthritis: state of the art and future perspectives","volume":"12","author":"Pelassa","year":"2023","journal-title":"Biology"},{"key":"R20-20250728","doi-asserted-by":"crossref","first-page":"1436193","DOI":"10.3389\/fimmu.2024.1436193","article-title":"Increased neutrophil extracellular trap formation in oligoarticular, polyarticular juvenile idiopathic arthritis and enthesitis-related arthritis: biomarkers for diagnosis and disease activity","volume":"15","author":"Tang","year":"2024","journal-title":"Front Immunol"},{"key":"R21-20250728","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1080\/09273948.2024.2428417","article-title":"MicroRNAs as biomarkers for uveitis in juvenile idiopathic arthritis","volume":"33","author":"Sharon","year":"2025","journal-title":"Ocul Immunol Inflamm"},{"key":"R22-20250728","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s12969-024-01006-x","article-title":"Peripheral blood regulatory T cells and disease activity, quality of life, and outcomes in children with juvenile idiopathic arthritis","volume":"22","author":"Quilis","year":"2024","journal-title":"Pediatr Rheumatol"},{"key":"R23-20250728","doi-asserted-by":"crossref","first-page":"1134747","DOI":"10.3389\/fimmu.2023.1134747","article-title":"Proteomic profiling of extracellular vesicles in synovial fluid and plasma from Oligoarticular Juvenile Idiopathic Arthritis patients reveals novel immunopathogenic biomarkers","volume":"14","author":"Raggi","year":"2023","journal-title":"Front Immunol"},{"key":"R24-20250728","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s41927-024-00390-x","article-title":"Associations of C reactive protein to albumin ratio, neutrophil to lymphocyte ratio, platelet to lymphocyte ratio with disease activity in patients with juvenile idiopathic arthritis","volume":"8","author":"Di Donato","year":"2024","journal-title":"BMC Rheumatol"},{"key":"R25-20250728","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1515\/rir-2024-0030","article-title":"14-3-3 Eta protein as a novel biomarker in early detection of uveitis in Egyptian juvenile idiopathic arthritis and rheumatoid arthritis patients: diagnostic and prognostic value","volume":"5","author":"Saif","year":"2025","journal-title":"Rheumatol Immunol Res"},{"key":"R26-20250728","doi-asserted-by":"crossref","first-page":"109776","DOI":"10.1016\/j.jnutbio.2024.109776","article-title":"Serum selenium, selenoprotein P and glutathione peroxidase 3 in rheumatoid, psoriatic, juvenile idiopathic arthritis, and osteoarthritis","volume":"135","author":"Wahl","year":"2025","journal-title":"J Nutr Biochem"},{"key":"R27-20250728","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.1007\/s10067-024-07061-9","article-title":"Anti\u03b1-1,4-D-polygalacturonic acid antibodies as a new biomarker for juvenile idiopathic arthritis","volume":"43","author":"Huang","year":"2024","journal-title":"Clin Rheumatol"},{"key":"R28-20250728","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.3390\/biom14121526","article-title":"Serum CS\/DS, IGF-1, and IGFBP-3 as biomarkers of cartilage remodeling in juvenile idiopathic arthritis: diagnostic and therapeutic implications","volume":"14","author":"Winsz-Szczotka","year":"2024","journal-title":"Biomolecules"},{"key":"R29-20250728","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s12969-023-00832-9","article-title":"Serum levels of soluble urokinase plasminogen activator receptor in juvenile idiopathic arthritis: a single-center Swedish case-control study","volume":"21","author":"Lewander","year":"2023","journal-title":"Pediatr Rheumatol"},{"key":"R30-20250728","doi-asserted-by":"crossref","first-page":"2437239","DOI":"10.1080\/08916934.2024.2437239","article-title":"Identification and validation of susceptibility modules and hub genes in polyarticular juvenile idiopathic arthritis using WGCNA and machine learning","volume":"58","author":"Liu","year":"2025","journal-title":"Autoimmunity"},{"key":"R31-20250728","doi-asserted-by":"crossref","first-page":"1400036","DOI":"10.3389\/fimmu.2024.1400036","article-title":"Transcriptomic signatures of classical monocytes reveal pro-inflammatory modules and heterogeneity in polyarticular juvenile idiopathic arthritis","volume":"15","author":"Hounkpe","year":"2024","journal-title":"Front Immunol"},{"key":"R32-20250728","doi-asserted-by":"crossref","first-page":"10619","DOI":"10.3390\/ijms241310619","article-title":"Immune cell-related genes in juvenile idiopathic arthritis identified using transcriptomic and single-cell sequencing data","volume":"24","author":"Zhang","year":"2023","journal-title":"Int J Mol Sci"},{"key":"R33-20250728","doi-asserted-by":"crossref","first-page":"5973","DOI":"10.2147\/IJGM.S482288","article-title":"Comprehensive characterization of Th2\/Th17 cells-related gene in systemic juvenile rheumatoid arthritis: evidence from mendelian randomization and transcriptome data using multiple machine learning approaches","volume":"17","author":"Wang","year":"2024","journal-title":"Int J Gen Med"},{"key":"R34-20250728","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12969-023-00949-x","article-title":"Establishment and analysis of a novel diagnostic model for systemic juvenile idiopathic arthritis based on machine learning","volume":"22","author":"Ding","year":"2024","journal-title":"Pediatr Rheumatol Online J"},{"key":"R35-20250728","doi-asserted-by":"crossref","first-page":"1371371","DOI":"10.3389\/fcimb.2024.1371371","article-title":"Construction and validation of a machine learning model for the diagnosis of juvenile idiopathic arthritis based on fecal microbiota","volume":"14","author":"Tu","year":"2024","journal-title":"Front Cell Infect Microbiol"},{"key":"R36-20250728","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/MNM.0000000000001822","article-title":"Machine learning diagnosis of active Juvenile Idiopathic Arthritis on blood pool [99M Tc] Tc-MDP scintigraphy images","volume":"45","author":"Kian Ara","year":"2024","journal-title":"Nucl Med Commun"},{"key":"R37-20250728","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s12969-023-00842-7","article-title":"Knee acoustic emissions as a noninvasive biomarker of articular health in patients with juvenile idiopathic arthritis: a clinical validation in an extended study population","volume":"21","author":"Goossens","year":"2023","journal-title":"Pediatr Rheumatol Online J"},{"key":"R38-20250728","first-page":"645","article-title":"Active vibrational Achilles tendon sensing for identifying and characterizing inflammatory symptomatology in enthesitis related arthritis","volume":"PP","author":"Goossens","year":"2024","journal-title":"IEEE Trans Biomed Eng"}],"container-title":["Current Opinion in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/BOR.0000000000001109","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T17:00:36Z","timestamp":1753722036000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/BOR.0000000000001109"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,20]]},"references-count":38,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/bor.0000000000001109","relation":{},"ISSN":["1040-8711","1531-6963"],"issn-type":[{"value":"1040-8711","type":"print"},{"value":"1531-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,20]]}}}